MENU
ALNY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Alnylam Pharmaceuticals (ALNY) Earnings Date & Reports
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
ALNY is expected to report earnings to fall 19.60% to $1.60 per share on July 30
Q2'26
Est.
$1.60
Q1'26
Beat
by $1.08
Q4'25
Beat
by $0.06
Q3'25
Beat
by $2.38
Q2'25
Beat
by $0.91
The last earnings report on April 30 showed earnings per share of $1.99, beating the estimate of 91 cents. With 225.45K shares outstanding, the current market capitalization sits at 36.40B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of therapeutics based on RNA interference
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
675 West Kendall Street
Phone
+1 617 551-8200
Employees
2500
Web
https://www.alnylam.com